ArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twelve analysts that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has assigned...